Company news

Bio-Techne Corp news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE

May 29, 2024

Bio-Techne to present at the 2024 leerink partners healthcare crossroads conference

May 22, 2024

Bio-Techne highlights recently announced top-line biomarker data from partner, Regulus Therapeutics, using the company's proprietary technology

May 21, 2024

Bio-Techne to present at the bofa securities health care conference 2024

May 7, 2024

Bio-Techne to present at the 27th annual meeting of the american society of gene & cell therapy (ASGCT)

May 6, 2024

Bio-Techne releases third quarter fiscal 2024 results

April 30, 2024

Bio-Techne appoints Dr. Judith Klimovsky to board of directors

April 29, 2024

Bio-Techne announces new distribution agreement with Thermo Fisher Scientific

April 28, 2024

Bio-Techne and Novomol-Dx announce point-of-care ocular biomarker assay

April 25, 2024

Bio-Techne files Patent infringement lawsuit against Molecular Instruments

April 22, 2024

Bio-Techne to host conference call on May 1, 2024, to announce third quarter fiscal 2024 financial results

April 9, 2024

BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY

April 7, 2024

Bio-Techne to present at the 2024 american association for cancer research (AACR) conference

April 2, 2024

BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS

March 31, 2024

Bio-Techne and Nikon Instruments Inc. announce partnership to expand access to innovative spatial biology services

March 27, 2024

Bio-Techne receives european IVDR certification for diagnostic test to monitor chronic myeloid leukemia

March 21, 2024

Bio-Techne to present at the keybanc life sciences & medtech investor forum

March 11, 2024

Bio-Techne to present at the barclays 26th annual global healthcare conference

March 5, 2024

Bio-Techne releases second quarter fiscal 2024 results

January 31, 2024

Bio-Techne's advanced cell diagnostics (ACD) sets new standard in spatial biology with protease-free RNAscope multiomics

January 28, 2024

Lunaphore and ACD revolutionize spatial biology research with the launch of the first fully automated, same-section, hyperplex multiomics application

January 24, 2024

SCIENTISTS AT THE WCBP CONFERENCE HIGHLIGHT ADVANCEMENTS IN PROTEIN BIOTHERAPEUTIC CHARGE HETEROGENEITY CHARACTERIZATION USING THE MauriceFlex™ SYSTEM

January 23, 2024

Bio-Techne to host conference call on February 1, 2024, to announce second quarter fiscal 2024 financial results

January 15, 2024

Bio-Techne announces appointment of matthew f. McManus as President, Diagnostics and Genomics Segment

January 4, 2024

Bio-Techne to showcase cell and gene therapy manufacturing tools at phacilitate advanced therapies week 2024

January 3, 2024

Bio-Techne to present at the 42nd annual j.p. morgan healthcare conference

December 20, 2023

Bio-Techne announces submission of FDA Drug Master File for ExCellerate GMP iPSC Expansion Medium supporting stem cell therapy

December 19, 2023

Bio-Techne to present at the 6th annual evercore isi healthconx conference

November 26, 2023

Asuragen to present novel clinical testing data at AMP 2023 conference

November 1, 2023

Bio-Techne releases first quarter fiscal 2024 results

October 30, 2023

Leading research institutes to present new data using Lunaphore's COMET™ technology at the society for immunotherapy of cancer (sitc) 38th annual meeting

October 24, 2023

Bio-Techne appoints Kim Kelderman as Chief Executive Officer

October 18, 2023

Bio-Techne achieves ISO 13485 certification for its Wallingford, ct manufacturing facility

October 15, 2023

Bio-Techne to host conference call on October 31, 2023, to announce first quarter fiscal 2024 financial results

October 9, 2023

Dr. Jordan Laser awarded AMP meritorious service award

September 27, 2023

SCIENTISTS AT CE PHARM CONFERENCE DESCRIBE HOW Maurice™ AND MauriceFlex™ SYSTEMS TRANSFORM THEIR PROTEIN ANALYSIS

September 26, 2023

Bio-Techne integrates its Maurice system with the thermo scientific chromeleon chromatography data system

September 25, 2023

Bio-Techne issues 2023 corporate sustainability report

September 24, 2023

Cizzle and Bio-Techne Announce Completion of Evaluation Programme for Detection of CIZ1B Using ProteinSimple Branded Simple Western™ Platform

September 18, 2023

Bio-Techne announces 2023 Investor Day and webcast

August 23, 2023

Bio-Techne to present at the ubs medtech, tools and Genomics Summit 2023

August 14, 2023

Bio-Techne ends collaboration program with Akoya to automate RNAscope on the phenocycler fusion

August 13, 2023

Bio-Techne releases fourth quarter fiscal 2023 results

August 7, 2023

Bio-Techne to host conference call on August 8, 2023, to announce fourth quarter and fiscal 2023 financial results

July 12, 2023

Bio-Techne completes Lunaphore acquisition

July 9, 2023

Bio-Techne to acquire Lunaphore

June 21, 2023

Bio-Techne successful on claim of reverse engineering by Miltenyi biotec

May 31, 2023

Bio-Techne to present at the 2023 jefferies healthcare conference

May 24, 2023

Exosome Diagnostics releases interim results from clinical study of prostate cancer risk Test

May 17, 2023

Bio-Techne commercializes RNAscope spatial biology workflow for the Standard BioTools Hyperion Imaging System

May 15, 2023

← Newer news releases · Older news releases →

Calls

The 5 newest of 27 calls. Every call is listed under its year.

Decks

The 5 newest of 16 decks. Every deck is listed under its year.